Additionally, the CHRAC1 level was significantly associated with pathological stages of kidney renal clear cell carcinoma (KIRC), adrenocortical carcinoma (ACC) and PAAD patients (Fig. S2). The gene discussed is CHRAC1; the disease is adrenal cortex carcinoma.